- funding probability score
- total disclosed funding
- last round valuation estimate
- disclosed funding rounds
- latest round
- latest funding stage
- next round estimate
- development stage
- number of investors
- number of competitors
- monthly web visits
- twitter followers
- Apta Biosciences has developed a proprietary, groundbreaking method for creating synthetic alternatives to antibodies, a core component of medical diagnostics and therapeutics. The company is a spin-out from Fujitsu, where the technology was developed over the past 10+ years in Singapore and Japan.
Apta Biosciences has offices in London and Singapore.
There is much more to this profile.
Log in or sign up for free to see the whole thing.
Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats